Tadalafil
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00820 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 36 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 2 | hypertrichosis (disease) | KG + DL |
| 3 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 4 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 5 | isolated genetic hair shaft abnormality | KG + DL |
| 6 | familial isolated trichomegaly | KG + DL |
| 7 | kyphoscoliotic heart disease | KG + DL |
| 8 | migraine with brainstem aura | KG + DL |
| 9 | migraine disorder | KG + DL |
| 10 | hypotrichosis simplex of the scalp | KG + DL |
| 11 | Raynaud disease | KG + DL |
| 12 | congenital hypotrichosis milia | KG + DL |
| 13 | alopecia | KG + DL |
| 14 | diffuse alopecia areata | KG + DL |
| 15 | genetic alopecia | KG + DL |
| 16 | familial clubfoot due to 17q23.1q23.2 microduplication | KG + DL |
| 17 | obsolete patella aplasia, coxa vara, and tarsal synostosis | KG + DL |
| 18 | pulmonary hypertension, primary, autosomal recessive | KG + DL |
| 19 | prostate calculus | KG + DL |
| 20 | pseudopelade of Brocq | KG + DL |
| 21 | 16q24.1 microdeletion syndrome | KG + DL |
| 22 | isolated pulmonary capillaritis | KG + DL |
| 23 | primary interstitial lung disease specific to childhood | KG + DL |
| 24 | coxopodopatellar syndrome | KG + DL |
| 25 | chromosome 17q23.1-q23.2 deletion syndrome | KG + DL |
| 26 | hypoalphalipoproteinemia | KG + DL |
| 27 | congenital pulmonary lymphangiectasia | KG + DL |
| 28 | amenorrhea (disease) | KG + DL |
| 29 | congenital alveolar capillary dysplasia | KG + DL |
| 30 | cor pulmonale | KG + DL |
| 31 | spinal cord ischemia | KG + DL |
| 32 | ABri amyloidosis | KG + DL |
| 33 | pulmonary hypertension, primary | KG + DL |
| 34 | idiopathic pulmonary arterial hypertension | KG + DL |
| 35 | peripheral vascular disease | KG + DL |
| 36 | pulmonary arterial hypertension | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.